Improvement in Lipids after Switch to Boosted Atazanavir or Darunavir in Children/adolescents with Perinatally Acquired HIV on Older Protease Inhibitors: Results from the Pediatric HIV/AIDS Cohort Study
HIV medicine(2017)
摘要
Dyslipidaemia is common in perinatally HIV‐infected (PHIV) youth receiving protease inhibitors (PIs). Few studies have evaluated longitudinal lipid changes in PHIV youth after switch to newer PIs.
更多查看译文
关键词
atazanavir,children,darunavir,lipids,longitudinal,perinatally HIV-infected
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要